• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种使用标准化营养保健品治疗脱发的新型多靶点方法。

A Novel Multi-Targeting Approach to Treating Hair Loss, Using Standardized Nutraceuticals.

作者信息

Farris Patricia K, Rogers Nicole, McMichael Amy, Kogan Sophia

出版信息

J Drugs Dermatol. 2017 Nov 1;16(11):s141-s148.

PMID:29141069
Abstract

Hair loss is a complicated problem that causes significant concern for those who are affected. Patients seeking medical treatment have limited options that include topical minoxidil and oral finasteride. While these treatments are backed by long term clinical use and research outcomes, many patients find topical minoxidil difficult to incorporate into their daily routine and some are concerned with the side effects associated with finasteride. In the office setting, patients may be treated with more invasive procedures such as platelet-rich plasma injections (PRP) and hair transplantation, treatments that often must be repeated and can lead to a costly investment. Consumers are increasingly interested in natural treatments for hair loss. Many turn to basic supplements only to be disappointed when they fail to deliver due to lack of standardization and efficacy. In this paper we review the benefits of a nutraceutical containing a specific blend of highly purified, standardized, bio-optimized, and bioavailable botanical extracts to treat hair loss. These phytoactives were selected because of their diverse multi-modal biologic activity against inflammation, DHT, stress mediators, oxidative damage, and intermediary signaling cascades. This supplement represents a paradigm shift as it addresses not only the factors that trigger hair loss but the downstream mediators of inflammation as well. Multi-center clinical studies are currently underway to confirm the efficacy and benefits of this unique nutraceutical.

J Drugs Dermatol. 2017;16(11 Suppl):s141-148.

.
摘要

脱发是一个复杂的问题,令受其影响的人深感担忧。寻求治疗的患者选择有限,包括外用米诺地尔和口服非那雄胺。虽然这些治疗方法有长期临床应用和研究结果的支持,但许多患者发现外用米诺地尔难以融入日常生活,还有一些人担心非那雄胺的副作用。在诊所环境中,患者可能会接受更具侵入性的治疗,如富血小板血浆注射(PRP)和植发,这些治疗通常需要重复进行,而且可能导致高昂的费用。消费者对脱发的自然疗法越来越感兴趣。许多人求助于基本的补充剂,但由于缺乏标准化和疗效而未能达到预期效果,这让他们感到失望。在本文中,我们综述了一种营养保健品的益处,该营养保健品含有特定混合的高度纯化、标准化、生物优化且生物可利用的植物提取物,用于治疗脱发。选择这些植物活性成分是因为它们对炎症、双氢睾酮、应激介质、氧化损伤和中间信号级联具有多种不同的生物活性。这种补充剂代表了一种范式转变,因为它不仅解决了引发脱发的因素,还解决了炎症的下游介质问题。目前正在进行多中心临床研究,以确认这种独特营养保健品的疗效和益处。

《皮肤药物学杂志》2017年;16(11增刊):s141 - 148。

相似文献

1
A Novel Multi-Targeting Approach to Treating Hair Loss, Using Standardized Nutraceuticals.一种使用标准化营养保健品治疗脱发的新型多靶点方法。
J Drugs Dermatol. 2017 Nov 1;16(11):s141-s148.
2
A Six-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Women With Self-Perceived Thinning Hair.一项为期六个月的随机双盲安慰剂对照研究,评估一种营养补充剂对自我感觉头发稀疏的女性促进头发生长的安全性和有效性。
J Drugs Dermatol. 2018 May 1;17(5):558-565.
3
Androgenetic alopecia: an evidence-based treatment update.雄激素性脱发:基于证据的治疗更新。
Am J Clin Dermatol. 2014 Jul;15(3):217-30. doi: 10.1007/s40257-014-0077-5.
4
Hair Loss Myths.脱发误区
J Drugs Dermatol. 2017 Jul 1;16(7):690-694.
5
New Insight Into the Pathophysiology of Hair Loss Trigger a Paradigm Shift in the Treatment Approach.对脱发病理生理学的新认识引发了治疗方法的范式转变。
J Drugs Dermatol. 2017 Nov 1;16(11):s135-s140.
6
Safety concerns when using novel medications to treat alopecia.使用新型药物治疗脱发的安全性问题。
Expert Opin Drug Saf. 2018 Nov;17(11):1115-1128. doi: 10.1080/14740338.2018.1533549. Epub 2018 Oct 25.
7
An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.口服非那雄胺与5%外用米诺地尔治疗男性雄激素性脱发的开放性、随机对照研究
Dermatology. 2004;209(2):117-25. doi: 10.1159/000079595.
8
Lasers, lights, and compounds for hair loss in aesthetics.激光、光线和化合物在美容中的脱发治疗。
Clin Dermatol. 2022 Jan-Feb;40(1):64-75. doi: 10.1016/j.clindermatol.2021.08.013. Epub 2021 Aug 8.
9
Multi-therapies in androgenetic alopecia: review and clinical experiences.雄激素性脱发的多种治疗方法:综述与临床经验
Dermatol Ther. 2016 Nov;29(6):424-432. doi: 10.1111/dth.12390. Epub 2016 Jul 18.
10
Efficacy and Safety of Minoxidil 2% Solution in Combination With a Botanical Hair Solution in Women With Female Pattern Hair Loss/Androgenic Alopecia.2%米诺地尔溶液联合植物性生发液治疗女性雄激素性脱发的疗效与安全性
J Drugs Dermatol. 2016 Apr;15(4):398-404.

引用本文的文献

1
Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation.抗脱发和生发药妆品的技术进步:多学科协同创新驱动的机制突破与产业前景
Aesthetic Plast Surg. 2025 Aug 11. doi: 10.1007/s00266-025-05077-3.
2
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair.一项随机、双盲、安慰剂对照研究,旨在评估一种含有标准化植物成分的营养补充剂对男性头发稀疏的安全性和有效性。
J Cosmet Dermatol. 2025 Jan;24(1):e16778. doi: 10.1111/jocd.16778.
3
Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines.
已知具有促进头发生长作用的营养保健品不会干扰他莫昔芬在 MCF7、T47D 和 BT483 乳腺癌细胞系中的抑制作用。
PLoS One. 2024 Feb 26;19(2):e0297080. doi: 10.1371/journal.pone.0297080. eCollection 2024.
4
Oral and Topical Administration of a Standardized Saw Palmetto Oil Reduces Hair Fall and Improves the Hair Growth in Androgenetic Alopecia Subjects - A 16-Week Randomized, Placebo-Controlled Study.标准化锯棕榈油的口服和局部给药可减少雄激素性脱发患者的脱发并促进头发生长——一项为期16周的随机、安慰剂对照研究。
Clin Cosmet Investig Dermatol. 2023 Nov 11;16:3251-3266. doi: 10.2147/CCID.S435795. eCollection 2023.
5
Androgenetic alopecia: An update.雄激素性脱发:最新进展。
JAAD Int. 2023 Jul 22;13:150-158. doi: 10.1016/j.jdin.2023.07.005. eCollection 2023 Dec.
6
Caizhixuan hair tonic regulates both apoptosis and the PI3K/Akt pathway to treat androgenetic alopecia.采之轩育发液通过调控细胞凋亡和 PI3K/Akt 通路治疗雄激素性脱发。
PLoS One. 2023 Feb 24;18(2):e0282427. doi: 10.1371/journal.pone.0282427. eCollection 2023.
7
HY7015 and Turcz. Extract Promotes Human Dermal Papilla Cell Cytoprotective Effect and Hair Regrowth Rate in C57BL/6 Mice.HY7015 和 Turcz. 提取物促进 C57BL/6 小鼠人真皮乳头细胞的细胞保护作用和毛发生长速度。
Molecules. 2022 Nov 25;27(23):8235. doi: 10.3390/molecules27238235.
8
Nutraceuticals for Androgenetic Alopecia.用于雄激素性脱发的营养保健品。
J Clin Aesthet Dermatol. 2022 Mar;15(3):26-29.
9
A Prospective Six-month Single-blind Study Evaluating Changes in Hair Growth and Quality Using a Nutraceutical Supplement in Men and Women of Diverse Ethnicities.一项为期六个月的前瞻性单盲研究,评估一种营养补充剂对不同种族男性和女性头发生长及发质变化的影响。
J Clin Aesthet Dermatol. 2022 Jan;15(1):21-26.
10
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.雄激素性脱发的治疗选择:疗效、副作用、依从性、经济考虑因素和伦理问题。
J Cosmet Dermatol. 2021 Dec;20(12):3759-3781. doi: 10.1111/jocd.14537. Epub 2021 Nov 6.